Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
1.
Rev. saúde pública ; 46(5): 886-893, out. 2012. tab
Article in Portuguese | LILACS | ID: lil-655041

ABSTRACT

OBJETIVO: Analisar os fatores associados ao uso de substâncias estimulantes por caminhoneiros para se manterem acordados. MÉTODOS: Survey com 854 motoristas em oito locais de concentração de caminhoneiros (sete postos de gasolina e um posto aduaneiro em região de fronteira) em cinco municípios do Rio Grande do Sul, em 2006. O desfecho "uso de rebite" foi categorizado em "sim" ou "não". Foi realizada análise de regressão de Poisson com variância robusta para a seleção de variáveis do modelo, que foi composto por níveis socioeconômicos, demográficos, de informações sobre a profissão e sobre o consumo de álcool. RESULTADOS: O consumo de rebite para se manter acordado foi declarado por 12,4% dos caminhoneiros de forma isolada ou em combinação com outras substâncias (café, guaraná em pó, energéticos, cocaína aspirada). O rebite foi a substância mais citada por aqueles que consumiam algo para ficar acordados. A ingestão de bebidas alcoólicas foi prática de mais de 70% dos entrevistados, dos quais 45,1% relataram consumo pelo menos uma vez por semana. O uso de rebite esteve associado às faixas etárias mais jovens, ao aumento da renda, à maior duração das viagens e ao consumo de álcool. DISCUSSÃO: O aumento da remuneração dos caminhoneiros implica aumento da carga de trabalho. Isso produz desgaste físico e emocional, levando-os a buscar solução temporária no consumo de substâncias estimulantes. A redução do consumo abusivo de álcool e do uso ilícito de substâncias como anfetaminas por motoristas profissionais depende não só de políticas voltadas para a prevenção e tratamento de drogas, mas de políticas intersetoriais articuladas que garantam melhores condições de trabalho e de saúde aos caminhoneiros.


OBJECTIVE: To analyze factors associated with the use of stimulants by truck drivers to stay awake. METHODS: A survey with 854 drivers was carried out at eight truck stops (seven gas stations and one border patrol post) located at five cities in the State of Rio Grande do Sul (Southern Brazil) in 2006. The outcome "amphetamine use" was categorized as "yes" or "no". Poisson regression analysis with robust variance was conducted in order to select the variables that would be included in the model, which was composed of variables regarding socioeconomic and demographic characteristics, information on the profession and on alcohol consumption. RESULTS: Amphetamine use to stay awake was reported by 12.4% of the truck drivers, either in isolation or in combination with other substances (coffee, guaraná powder, energy drinks, snorted cocaine). Amphetamine was the most cited substance by those who consumed something to stay awake. The consumption of alcoholic drinks was mentioned by more than 70% of the interviewees; among those who drink, 45.1% reported that they use alcohol at least once a week. Amphetamine use was associated with younger age groups, wage increase, longer trips, and alcohol use. CONCLUSIONS: The increase in the truck drivers' wages implies increased workloads. This produces physical and emotional stress, which makes the truck drivers search for a temporary solution in the consumption of stimulants. The reduction in the abusive consumption of alcohol and in the illicit use of substances like amphetamines by professional drivers depends not only on policies addressing prevention and treatment for drug abuse, but also on integrated policies ensuring better working and health conditions to the truck drivers.


OBJETIVO: Analizar los factores asociados al uso de sustancias estimulantes por camioneros para mantenerse despiertos. MÉTODOS: Sondeo con 854 en ocho locales de concentración de camioneros (siete puestos de gasolina y un puesto de aduana en región de frontera) en cinco municipios de Rio Grande do Sul, Sur de Brasil, en 2006. El desenlace, uso de la anfetamina rebite, fue categorizado en "si" o "no". Se realizó análisis de regresión de Poisson con varianza robusta para la selección de variables del modelo, que fue compuesto por variables socioeconómicas, demográficas, de informaciones sobre la profesión y sobre el consumo de alcohol. RESULTADOS: El consumo de rebite para mantenerse despierto fue declarado por 12,4% de los camioneros de forma aislada o en combinación con otras sustancias (café, guaraná en polvo, energéticos, cocaína aspirada). El rebite fue la sustancia más citada por aquellos que consumían algo para permanecer despiertos. La ingestión de bebidas alcohólicas fue práctica de más del 70% de los entrevistados, de los cuales 45,1% relataron consumo por al menos una vez por semana. El uso de rebite estuvo asociado a los grupos etarios más jóvenes, al aumento de la renta, a la mayor duración de los viajes y al consumo de alcohol. DISCUSIÓN: El aumento de la remuneración de los camioneros implica aumento de la carga de trabajo. Esto produce desgaste físico y emocional, llevando a los camioneros a buscar solución temporal en el consumo de sustancias estimulantes. La reducción del consumo abusivo de alcohol y del uso ilícito de sustancias como anfetaminas por choferes profesionales depende no sólo de políticas direccionadas hacia la prevención y tratamiento de drogas, sino también de políticas intersectoriales articuladas que garanticen mejores condiciones de trabajo y de salud a los camioneros.


Subject(s)
Adult , Humans , Male , Middle Aged , Young Adult , Alcohol-Related Disorders/epidemiology , Amphetamine-Related Disorders/epidemiology , Automobile Driving/statistics & numerical data , Motor Vehicles , Occupational Diseases/epidemiology , Wakefulness/drug effects , Age Factors , Brazil/epidemiology , Cocaine-Related Disorders/epidemiology , Men's Health , Occupational Health , Risk Factors , Socioeconomic Factors
2.
J Indian Soc Pedod Prev Dent ; 2006 Mar; 24(1): 7-14
Article in English | IMSEAR | ID: sea-114973

ABSTRACT

The present study was undertaken to evaluate Midazolam as a Paediatric conscious sedative agent for a routine Indian dental setup and to compare its efficacy and safety when administered by intranasal and intramuscular routes, at a dosage of 0.2 mg/kg body weight. The present study was accomplished in two phases: Phase 1: Preliminary dose finding pilot study on 10 children. Phase 2: Single dose, randomized parallel clinical trial on 40 children between the ages of 2 and 5 years. These children were randomly assigned to two groups consisting of 20 subjects each. Group M, received Midazolam intramuscularly, while Group N received Midazolam intranasally. Both the intranasal and intramuscular groups showed highly significant decrease in crying levels, motor movements and sensory perception levels, post-sedation (P P < 0.001). Midazolam could be safely and successfully employed by intranasal and intramuscular routes for Paediatric conscious sedation in a routine dental setup with basic facilities at a dosage of 0.2 mg/ kg body weight. Whenever the clinical situation warrants a faster action, peak and recovery, the intranasal route should be the obvious choice.


Subject(s)
Administration, Intranasal , Anesthesia Recovery Period , Anesthesia, Dental , Body Weight , Child Behavior/drug effects , Child, Preschool , Conscious Sedation/methods , Cough/chemically induced , Crying , Female , Hiccup/chemically induced , Humans , Hypnotics and Sedatives/administration & dosage , Injections, Intramuscular , Male , Midazolam/administration & dosage , Motor Activity/drug effects , Pilot Projects , Safety , Single-Blind Method , Sneezing/drug effects , Time Factors , Wakefulness/drug effects
3.
Arq. neuropsiquiatr ; 63(3B): 748-750, set. 2005.
Article in English | LILACS | ID: lil-445153

ABSTRACT

OBJECTIVE: This paper reports the use of dexmedetomidine in three epileptic patients with cavernous angiomas that underwent awake surgery in order to map their speech areas. METHOD: Loading dose of dexmedetomidine varied from 1 microg/Kg/h to 3 microg/Kg/h over 20 minutes and maintenance dose from 0.4 microg/Kg/h to 0.8 microg/Kg/h. RESULTS: There was no occurrence of hemodynamic instability, convulsions or respiratory depression. Patients tolerated well the procedure. CONCLUSION: Dexmedetomidine was useful for awake craniotomy as it decreased patients level of consciousness but did not produce agitation. Laryngeal mask was not necessary to keep air ventilation.


OBJETIVO: Este trabalho relata o uso de desmedetomidina em três pacientes com angiomas cavernosos próximos a área de linguagem e epilepsia que foram operados acordados para mapeamento cortical. MÉTODO: A dose de ataque de dexmedetomidina variou de 1 mg/Kg/h a 3 mg/Kg/h durante 20 minutos e dose de manutenção de 0,4 mg/Kg/h a 0,8 mg/Kg/h. RESULTADOS: Os pacientes toleraram bem o procedimento e não houve instabilidade hemodinâmica, convulsões ou depressão respiratória. CONCLUSÃO: Dexmedetomidina foi útil nas craniotomias com o paciente acordado para mapeamento cortical pois gerou sedação sem agitação. A máscara laríngea não foi necessária para manter a ventilação nesses pacientes.


Subject(s)
Adult , Female , Humans , Male , Middle Aged , Craniotomy/methods , Dexmedetomidine , Hypnotics and Sedatives , Conscious Sedation/methods , Anesthetics, Combined , Epilepsy/surgery , Fentanyl , Midazolam , Propofol , Wakefulness/drug effects
5.
An. Acad. Nac. Med ; 156(1): 9-12, jan.-mar. 1996.
Article in Portuguese | LILACS | ID: lil-186545

ABSTRACT

As modificaçöes do ritmo sono-vigília, quando ocorrem na atividade aeroespacial, afetam o relógio biológico e a dessincronizaçäo tem origem principalmente no marcador da percepçäo da noite e do dia. Assim, o uso de soníferos torna-se importante pelos riscos da açäo residual e conseqüente embotamento cognitivo. Os medicamentos ansiolíticos de uso täo comum, dada a facilidade com que säo receitados, devem figurar entre os produtos cujos efeitos adversos säo desprezados, pois o alívio da angústia ganha prioridade. Finalmente os fármacos antidepressivos, em virtude da multiplicidade de estruturas químicas e mecanismos de açäo, envolvem efeitos iatrogênicos variados e perigosos para a atividade em questäo. Seguem-se recomendaçöes saneadoras.


Subject(s)
Humans , Autonomic Agents/pharmacology , Anti-Anxiety Agents/pharmacology , Antidepressive Agents/pharmacology , Astronauts , Aviation , Hypnotics and Sedatives/pharmacology , Sleep/drug effects , Wakefulness/drug effects
6.
Indian J Physiol Pharmacol ; 1995 Jul; 39(3): 299-301
Article in English | IMSEAR | ID: sea-108583

ABSTRACT

Intracerebral microinjections of gamma amino butyric acid were given bilaterally at the medial preoptic area (mPOA) to determine the possible role of this neurotransmitter in the genesis and regulation of sleep-wakefulness. GABA (50 micrograms/0.2 microliters) when administered through chronically implanted cannulae in free moving rats, did not produce any significant alterations in sleep-wakefulness. This may be attributed either to the non-involvement of GABA at the level of mPOA in the regulation of sleep, or to other factors like the low dose and rapid breakdown of the injected drug.


Subject(s)
Animals , Electroencephalography/drug effects , Male , Preoptic Area/drug effects , Rats , Rats, Wistar , Sleep/drug effects , Wakefulness/drug effects , gamma-Aminobutyric Acid/administration & dosage
7.
Indian J Physiol Pharmacol ; 1994 Jul; 38(3): 163-8
Article in English | IMSEAR | ID: sea-108280

ABSTRACT

The aim of the present study was to find out the changes in sleep-wakefulness and body temperature brought about by application of cholinergic agonist, carbachol, in the medial preoptic area (mPOA). Carbachol, when injected bilaterally into the mPOA of male rats, through chronically implanted cannulae, produced a fall in rectal temperature and long lasting arousal. There was temporal dissociation in the duration of changes produced in the two parameters. It is suggested that the cholinergic system at the medial preoptic area brings about arousal response and fall in body temperature through different circuits.


Subject(s)
Analysis of Variance , Animals , Body Temperature/drug effects , Body Temperature Regulation/drug effects , Carbachol/administration & dosage , Catheters, Indwelling , Electrophysiology , Male , Microinjections , Preoptic Area/drug effects , Rats , Rats, Wistar , Sleep/drug effects , Wakefulness/drug effects
8.
Gac. méd. Méx ; 126(6): 519-22, nov.-dic. 1990. tab
Article in Spanish | LILACS | ID: lil-177263

ABSTRACT

El propósito de este trabajo fue analizar el efecto de un derivado de la benzodiazepina sobre el ciclo vigilia-sueño, que no había sido estudiado. Para este propósito, se le administraron a ratas Wistar 0.9 mg/kg de un derivado clorado de la beta lactama de 1,5 benzodiazepina por vía intraperitoneal, analizando su acción mediante diez horas de registro poligráfico contínuo. Los resultados muestran que esta substancia disminuye el estado de vigilia e incrementan ligeramente el sueño lento y, de manera estadísticamente significativa (p<0.05), el sueño paradójico. Asimismo, la latencia de la primera fase de sueño paradójico se reduce de manera importante. Estos hallazgos indican que la substancia, analizada bajo las condiciones experimentales descritas, facilita la inducción y el mantenimiento del sueño


Subject(s)
Rats , Benzodiazepines/administration & dosage , Benzodiazepines/adverse effects , Benzodiazepines/pharmacokinetics , Diazepam/administration & dosage , Diazepam/adverse effects , Diazepam/pharmacokinetics , Electromyography/classification , Electromyography/statistics & numerical data , Electromyography/methods , Nitrazepam/administration & dosage , Nitrazepam/adverse effects , Nitrazepam/pharmacokinetics , Sleep, REM , Sleep, REM/physiology , Sleep , Sleep/physiology , Wakefulness/drug effects , Wakefulness/physiology
9.
Rev. mex. anestesiol ; 13(2): 101-4, abr.-jun. 1990.
Article in Spanish | LILACS | ID: lil-99028

ABSTRACT

Dada la complejidad del Sistema Nervioso Central (S.N.C.), escenario de las acciones anestesiológicas, en este trabajo se analiza la interacción de los fármacos empleados desde la premedicación y transanestésico; con el ciclo sueño-vigilia, al actual sobre los núcleos y neurotransmisores que intervienen en la regulación de estos estados de vigilancia.


Subject(s)
Humans , Child , Wakefulness/drug effects , Wakefulness/physiology , Central Nervous System/physiology , Hypnotics and Sedatives/adverse effects , Hypnotics and Sedatives/pharmacology , Sleep , Sleep/physiology
SELECTION OF CITATIONS
SEARCH DETAIL